[Federal Register: February 12, 2003 (Volume 68, Number 29)]
[Notices]
[Page 7147]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr12fe03-59]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances, Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on July 2, 2002, Cedarburg
Pharmaceuticals, LLC, 870 Badger Circle, Grafton, Wisconsin 53024, made
application by renewal to the Drug Enforcement Administration (DEA) for
registration as a bulk manufacturer of the basic classes of controlled
substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
------------------------------------------------------------------------
The firm will manufacturer these controlled substances for
distribution to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, DC 20537, Attention: DEA Federal Register Representative
(CCR), and must be filed no later than April 14, 2003.
Dated: February 5, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-3502 Filed 2-11-03; 8:45 am]
BILLING CODE 4410-09-M